John Kaczmar to Chemotherapy, Adjuvant
This is a "connection" page, showing publications John Kaczmar has written about Chemotherapy, Adjuvant.
Connection Strength
0.052
-
Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2022 04 01; 28(7):1345-1352.
Score: 0.052